Some studies using animals have shown that the genetic deletion of STAT5 in the liver is associated with a high susceptibility to fatty liver disease, fibrosis, and cancer, pointing to a protective role of hepatic STAT5 in mouse models of chronic liver disease [158]. This evidence concerns the gene STAT5A and cancer.